Default company panoramic image

GenOssis LLC

GenOssis designs and develops innovative orthopedic implants for superior bone fracture treatment.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Fort Washington, PA, USA
  • Currency USD
  • Employees 3
  • Website

Company Summary

GenOssis is an early stage medical device company. We develop and commercialize orthopedic devices for fracture care. Our mission is to create premium products that provide optimal solutions for bone healing in an atraumatic manner. The orthopedic implant sector enjoys a robust growth and is an attractive investment proposition due to its relatively low regulatory risk, manageable development costs and high gross margins.


  • Default avatar
    Wolfgang Oster, MD, PhD

    Dr. Oster is the Managing Partner for the Life Science Fund of Polytechnos Venture-Partners. His portfolio companies located and active in Europe, US, Israel, and Asia.
    His track record as entrepreneur, executive and investor includes two major trade sales (U.S. BioScience, BiPar), and 5 IPOs (Devgen, Jerini, Micrus, OncoMethylome, Addex). He sits on the Board of Directors of Cappella, IMI, ImmunoGenes, Hemacon, Provid, Noblegen and Oncoceutics

  • Default avatar
    Amit Sinha, MBA
    President & CEO

    20 years in healthcare. He worked in product development for Synthes managing an $80M product group and taking multiple products from concept through launch. At Integra he took their cranial system from concept to launch and also worked on M&A projects facilitating three acquisitions. At Globus Medical he developed and executed a business plan to create the company’s promotional education division training 500 surgeons.

  • Default avatar
    Mark Spilker, PhD

    Mechanical Engineer from MIT. Led product development and has launched many new products at Integra. Currently he heads product development as Vice President of Research and Development at the Musculoskeletal Transplant Foundation which is the nation’s largest tissue bank.

  • Default avatar
    Grif Bates, MBA

    Grif Bates is a Marketing executive with 16 years of experience at Merck & Co. and 8 years at Procter & Gamble. His work experience covers both US and international markets, and he has managed products in several therapeutic categories including cardiovascular, respiratory and analgesia. He has an MBA from the Darden School at the University of Virginia.

  • Default avatar
    Glenn Hartz, BS
    Finance & Accountung

    Glenn Hartz has had a long career in finance. Commercial lender and member of the school board of Eastern Lancaster County.


  • Default avatar
    Steve Goodman & Fahd Riaz , Morgan Lewis & Bockius, Philadelphia, PA
    Default avatar
    Shah Accounting Services, Hatfield, PA

Previous Investors

  • Default avatar
    A. Tati, R. Bown, Dr. A Moinfar, R. Srinivasan, G. Bates,
    Default avatar
    R. McLaughlin, A. Sinha, O. Oechsle, Dr. W. Oster, Brig. R. Witmer